Cargando…
COVID-19
The coronavirus disease 2019 (COVID-19) outbreak has spread throughout the globe and much time has passed since it was declared as a pandemic by the World Health Organization (WHO). COVID-19: Diagnosis and Management provides clinicians and scholars all the information on this disease in 2 volumes....
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Sharjah :
Bentham Science Publishers,
2021.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Mu 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_on1260348506 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 210717s2021 xx o ||| 0 eng d | ||
| 040 | |a EBLCP |b eng |c EBLCP |d SFB |d OCLCO |d OCLCF |d OCLCO | ||
| 020 | |a 9781681088051 | ||
| 020 | |a 1681088053 | ||
| 029 | 1 | |a AU@ |b 000069837705 | |
| 035 | |a (OCoLC)1260348506 | ||
| 050 | 4 | |a RA644.C67 |b .M588 2021 | |
| 082 | 0 | 4 | |a 362.1962414 |2 23 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Mittal, Neeraj. | |
| 245 | 1 | 0 | |a COVID-19 |h [electronic resource]. |
| 260 | |a Sharjah : |b Bentham Science Publishers, |c 2021. | ||
| 300 | |a 1 online resource (225 p.) | ||
| 500 | |a Description based upon print version of record. | ||
| 505 | 0 | |a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Prevention of COVID-19: Facts to Overcome the Myths -- Rajesh Kumar1, Mangesh Pradeep Kulkarni1, Sheetu Wadhwa1 and Soundappan Kathirvel2,* -- INTRODUCTION -- MEASURES TO PREVENT THE SPREAD, ASSOCIATED MYTHS AND FACTS -- Personal Protective Equipment (PPE) -- Head Covers -- Face Shield -- Mask -- Goggles -- Gloves -- Shoe Covers -- Gowns or Coveralls -- SANITIZATION AND DISINFECTION -- Hand Hygiene -- For Public -- Prevention of COVID-19 Among Frontline Healthcare Workers | |
| 505 | 8 | |a Cleaning of Vegetables-Fruits -- Safe Handling of Currency and Paper Documents -- Cough or Respiratory Etiquettes -- Precautions to be Taken While Coughing/Sneezing or Any Physical Contact -- Spitting or Littering in Public -- Disinfection of Public Places -- Disposal and Disinfection of PPEs -- WATER TREATMENT AND WASTE MANAGEMENT -- Management of Water and Faecal Waste -- Safety of Water Supplies -- SOCIAL MEASURES -- Physical Distancing -- Quarantine and Isolation -- Home Quarantine -- Institutional Quarantine -- Staff Guidelines -- Utility Guidelines -- Lockdown and Travel Restrictions | |
| 505 | 8 | |a Zonal Classification of the Geography -- PROPHYLAXIS FOR COVID-19 -- Dietary Recommendations for the Prevention of COVID-19 -- General Measures -- Medicinal Plant Measures/Procedures -- Medical Prophylaxis for Healthcare Workers and Contacts of a Positive Patient -- REGULAR SCREENING -- PRECAUTIONS FOR TRAVEL -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Current Treatment Methods for Coronavirus Disease-19 -- Kuldeep Kumar1, Sonal1, Pankaj Bhatia1, Dhandeep Singh1, Amteshwar S. Jaggi1 and Nirmal Singh1,* | |
| 505 | 8 | |a INTRODUCTION -- OVERVIEW OF VARIOUS TREATMENT STRATEGIES FOR COVID-19 -- Hydroxychloroquine -- HCQ in Treatment of COVID-19 -- Remdesivir -- Remdesivir in Treatment of COVID-19 -- Lopinavir/Ritonavir -- Lopinavir/Ritonavir in Treatment of COVID-19 -- Favipiravir -- Favipiravir in Treatment of COVID-19 -- Azithromycin (AZ) -- AZ in COVID-19 Treatment -- Arbidol -- Arbidol in Treatment of COVID-19 -- Ribavirin -- Ribavirin in COVID-19 Treatment -- Teicoplanin -- Teicoplanin in COVID-19 Treatment -- Ivermectin -- Ivermectin in Treatment of COVID-19 -- Nitazoxanide | |
| 505 | 8 | |a Nitazoxanide in COVID-19 Treatment -- Corticosteroids -- Corticosteroids in the Treatment of COVID-19 -- Immuno Modulating Agents-Interferons (IFN's) -- IFN's in Treatment of COVID-19 -- Monoclonal Antibody Therapy -- 80R Immunoglobulin G1 (IgGI) -- CR3014 -- Monoclonal Antibody Therapy in COVID-19 Treatment -- Tocilizumab -- Sarilumab -- Limitations and Suggestions Regarding mAb's -- Triple Therapy -- Miscellaneous Drugs -- Herbal Drugs for COVID-19 -- Glycyrrhizin -- Glycyrrhizin in COVID-19 -- Hesperetin -- Baicalin -- Scutellarin -- Plasma Therapy | |
| 500 | |a Plasma Therapy in the Treatment of COVID-19. | ||
| 520 | |a The coronavirus disease 2019 (COVID-19) outbreak has spread throughout the globe and much time has passed since it was declared as a pandemic by the World Health Organization (WHO). COVID-19: Diagnosis and Management provides clinicians and scholars all the information on this disease in 2 volumes. Readers will find a concise and visual reference for this viral disease and will be equipped with the knowledge to assess and manage Sar-Cov-2 infection cases in clinical settings. This book is divided into two parts (I and II). Part I provides comprehensive information about 1 History of Coronaviruses, 2 Epidemiology of COVID-19, 3 Clinical presentation of this viral disease and 4 COVID-19 diagnosis. Part II covers broader topics about this communicable disease including 1 the prevention and treatment methodology, 2 mortality and long-term complications, 3 COVID-19 vaccines and future perspectives. Key Features: - Covers all the aspects of COVID-19 making this a perfect textbook for virology and medical students. -Chapter wise description and segregation of topics from pathophysiology to diagnosis and management of COVID-19. -Six chapters in the first part which focus on clinical basics of COVID-19. -Six chapters in the second part which cover broader topics for practical infection control. -Multiple tables and figures which summarize and highlight important points. -Presents a summary of the current standards for the evaluation and diagnosis of COVID-19. - Features a detailed list of references, abbreviations, and symbols. This book is an essential textbook reference for medical students, scientists (virologists, pulmonologists) and public health officials who are required to understand COVDI-19 diagnosis and management as part of their clinical training or professional work. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a COVID-19 vaccines. | |
| 650 | 0 | |a Political planning. | |
| 650 | 2 | |a COVID-19 Vaccines | |
| 650 | 6 | |a Vaccins contre la COVID-19. | |
| 650 | 6 | |a Politique publique. | |
| 650 | 7 | |a COVID-19 vaccines |2 fast | |
| 650 | 7 | |a Political planning |2 fast | |
| 653 | |a Communicable Diseases | ||
| 653 | |a Medical | ||
| 700 | 1 | |a Bhadada, Sanjay Kumar. | |
| 700 | 1 | |a Katare, O. P. | |
| 776 | 0 | 8 | |i Print version: |a Mittal, Neeraj |t COVID-19: Diagnosis and Management - Part II |d Sharjah : Bentham Science Publishers,c2021 |z 9781681088075 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=6676568 |z Texto completo |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL6676568 | ||
| 994 | |a 92 |b IZTAP | ||